SHR-1894

· Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-1894, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects [Phase 1]